X0306 4 2018-05-16 0001099800 Edwards Lifesciences Corp EW 0001446989 Ullem Scott B. ONE EDWARDS WAY IRVINE CA 92614 1 CVP, CFO Common Stock 2018-05-16 4 M 0 9712.0000 0 A 18456.0000 D Common Stock 2018-05-16 4 F 0 4816.0000 136.4300 D 13640.0000 D Common Stock 62780.0000 I By Trust Performance Rights 2018-05-16 4 M 0 9712.0000 0.0000 D 2018-05-31 Common Stock 9712.0000 0.0000 D On May 14, 2015, the Reporting Person was granted a target number of shares (5,550) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 16, 2018, the Compensation Committee of the Issuer's Board of Directors determined that 175% of the target shares vested as of May 14, 2018, and the actual number of shares vested are reflected on this Form. Such shares became issuable following the May 16, 2018 determination. Paid out in excess of target amount which was at 175% of target (rounded down to the nearest whole share) Linda J. Park, Attorney-in-Fact 2018-05-18